MedPath
HSA Approval

XILONIBSA Solution for Injection 2% 1:80000

SIN14157P

XILONIBSA Solution for Injection 2% 1:80000

XILONIBSA Solution for Injection 2% 1:80000

June 11, 2012

FONDACO PTE LTD

FONDACO PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFONDACO PTE LTD
Licence HolderFONDACO PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBMUCOSAL

Medical Information

N01BB52

lidocaine, combinations

Manufacturer Information

FONDACO PTE LTD

Laboratorios Inibsa, S.A.

Active Ingredients

Lidocaine hydrochloride

20.00mg/ml

Lidocaine

Adrenaline tartrate 0.02274mg/ml eqv Adrenaline

0.0125mg/ml

Epinephrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XILONIBSA Solution for Injection 2% 1:80000 - HSA Approval | MedPath